These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 10427982
1. T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens. Grufman P, Wolpert EZ, Sandberg JK, Kärre K. Eur J Immunol; 1999 Jul; 29(7):2197-204. PubMed ID: 10427982 [Abstract] [Full Text] [Related]
2. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. Wolpert EZ, Grufman P, Sandberg JK, Tegnesjö A, Kärre K. J Immunol; 1998 Nov 01; 161(9):4499-505. PubMed ID: 9794374 [Abstract] [Full Text] [Related]
3. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens. Grufman P, Sandberg JK, Wolpert EZ, Kärre K. J Leukoc Biol; 1999 Aug 01; 66(2):268-71. PubMed ID: 10449165 [Abstract] [Full Text] [Related]
4. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C. Eur J Immunol; 1997 Feb 01; 27(2):421-30. PubMed ID: 9045913 [Abstract] [Full Text] [Related]
6. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others. Choi EY, Yoshimura Y, Christianson GJ, Sproule TJ, Malarkannan S, Shastri N, Joyce S, Roopenian DC. J Immunol; 2001 Apr 01; 166(7):4370-9. PubMed ID: 11254691 [Abstract] [Full Text] [Related]
7. Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens. Wettstein PJ. Immunogenetics; 1986 Apr 01; 24(1):24-31. PubMed ID: 2426194 [Abstract] [Full Text] [Related]
9. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo. Kim TS, Chung SW, Kim SH, Kang BY, Hwang SY, Lee JW. Cancer Gene Ther; 2000 Jun 01; 7(6):861-9. PubMed ID: 10880016 [Abstract] [Full Text] [Related]
10. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. Wild J, Grusby MJ, Schirmbeck R, Reimann J. J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922 [Abstract] [Full Text] [Related]
11. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells. Pilarski LM, Carayanniotis G. J Immunol; 1985 Dec 15; 135(6):3686-90. PubMed ID: 2415580 [Abstract] [Full Text] [Related]
12. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens. Korngold R, Leighton C, Mobraaten LE, Berger MA. Biol Blood Marrow Transplant; 1997 Jun 15; 3(2):57-64. PubMed ID: 9267665 [Abstract] [Full Text] [Related]
13. Antigen competition in cytotoxic T cell response to minor histocompatibility antigens. Lai PK. Transplantation; 1985 Jun 15; 39(6):638-43. PubMed ID: 3873732 [Abstract] [Full Text] [Related]
14. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M, Heirman C, Van Meirvenne S, Devos S, Corthals J, Moser M, Thielemans K. J Immunol; 1999 Jan 01; 162(1):144-51. PubMed ID: 9886380 [Abstract] [Full Text] [Related]
15. Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. Spencer JV, Braciale TJ. J Exp Med; 2000 May 15; 191(10):1687-98. PubMed ID: 10811862 [Abstract] [Full Text] [Related]
16. Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion. Ghosh A, Wolenski M, Klein C, Welte K, Blazar BR, Sauer MG. J Immunother; 2008 May 15; 31(2):121-31. PubMed ID: 18481382 [Abstract] [Full Text] [Related]
17. A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. Blanas E, Davey GM, Carbone FR, Heath WR. J Immunol; 2000 Mar 15; 164(6):2890-6. PubMed ID: 10706674 [Abstract] [Full Text] [Related]
18. Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection. Yoo KI, Jeon JY, Ryu SJ, Nam G, Youn H, Choi EY. Exp Mol Med; 2015 Feb 13; 47(2):e140. PubMed ID: 25676063 [Abstract] [Full Text] [Related]
19. Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens. Malarkannan S, Horng T, Eden P, Gonzalez F, Shih P, Brouwenstijn N, Klinge H, Christianson G, Roopenian D, Shastri N. Immunity; 2000 Sep 13; 13(3):333-44. PubMed ID: 11021531 [Abstract] [Full Text] [Related]
20. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens. Wettstein PJ, Colombo MP. J Immunol; 1987 Oct 01; 139(7):2166-71. PubMed ID: 2958540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]